Article
Antidepressants and Sleep: What Your Doctor May Not Have Told You
Depression
Depression
- Sleep disturbance is both a core symptom of depression and a recognised independent risk factor that can deepen and prolong it, so getting sleep right is central to recovery rather than a minor detail.
- Antidepressants affect sleep in different ways: SSRIs and SNRIs can be activating and suppress REM sleep (sometimes causing insomnia or vivid dreams), while sedating options like mirtazapine and trazodone can cause daytime drowsiness and morning grogginess.
- These effects are often underreported and underdiscussed, with patients and clinicians alike normalising them as "just the depression", which can quietly drive people to reduce or stop their medication without medical guidance.
- Solutions exist and shouldn't be left unspoken, including timing adjustments, dose reviews, switching medication, CBT-I, and alternative approaches such as the Flow tDCS headset. Anyone struggling should raise it with their prescriber rather than stopping medication abruptly.
Sleep and depression have a complicated relationship. Poor sleep is one of the most common and distressing symptoms of depression, and yet, frustratingly, the medications we most often use to treat depression can themselves have a significant impact on sleep.
This is something I hear about regularly from patients, and it's a side effect that, in my experience, doesn't get nearly enough attention in the consultation room.
If you're taking antidepressants and struggling with your sleep (whether that's difficulty getting off to sleep, waking in the night, vivid or disturbing dreams, or feeling exhausted during the day) you're not imagining it, and you're certainly not alone. In this article, I want to explain what's happening, why it matters, and what options are available to you.
Why sleep matters so much in depression
Sleep disturbance is one of the hallmark features of depression. Whether it's lying awake for hours with a racing mind, waking at 3am and being unable to get back to sleep, or sleeping far more than usual and still feeling completely depleted, disrupted sleep both reflects and worsens low mood. There is now considerable evidence showing that insomnia is not simply a symptom of depression, but an independent risk factor that can deepen and maintain it (ref), creating a cycle that can be genuinely difficult to break.
When treating depression, getting sleep right is not a minor detail; it's often central to recovery. This is also why it matters so much that we understand the ways antidepressant medication can affect sleep architecture and quality.
How antidepressants can affect sleep
Not all antidepressants affect sleep in the same way, and the picture is more nuanced than simply "antidepressants cause insomnia" or "antidepressants make you drowsy". A systematic review of 21 antidepressants found that, with few exceptions, SSRIs and SNRIs carry a higher risk of both insomnia and somnolence compared to placebo (ref). It’s important to also consider that everyone is unique and side effects to different antidepressants can vary enormously between individuals. Here are the main patterns I see in clinical practice:
SSRIs and SNRIs: activation and REM sleep suppression
SSRIs (such as sertraline, fluoxetine, and escitalopram) and SNRIs (such as venlafaxine and duloxetine) are the most commonly prescribed antidepressants in the UK. One of the well-recognised effects of these medications is that they can be activating, meaning they can increase alertness, and for some people cause or worsen insomnia, particularly when first starting treatment or when the dose is increased.
SSRIs and SNRIs may also significantly suppress REM sleep, which is the stage of sleep in which we dream (ref). This can initially feel like a benefit if you've been having disturbing or distressing dreams as part of your depression. However, REM sleep plays an important role in emotional processing and memory consolidation, so long-term suppression is not without consequence. Some people also find that when they reduce or stop their antidepressant, there can be a rebound effect with a surge of vivid, sometimes disturbing dreams as REM sleep returns.
For others, particularly at higher doses, SSRIs can cause poor quality or fragmented sleep, even when they were prescribed partly to help with these very symptoms.
Sedating antidepressants: daytime drowsiness and oversleeping
Some antidepressants are sedating in nature, with mirtazapine and trazodone being the most commonly used examples. These medications are sometimes deliberately chosen or prescribed at night when sleep is a significant problem, and for some patients this works well. However, sedation isn't always the same as restorative sleep, and there's an important distinction between feeling sedated and actually sleeping well. Sleeping too heavily and morning grogginess can be unacceptable to live with for some people, for example, many parents of young children simply cannot take medication that makes it hard to reliably wake in the night or be up for the school-run.
Daytime drowsiness, difficulty waking, and feeling unrefreshed in the morning are common complaints I hear from people on sedating antidepressants and some people can also experience these effects from SSRI medication. This has real consequences for daily functioning, work, driving, and quality of life, and it's something that deserves to be taken seriously rather than dismissed as an acceptable trade-off.
Vivid dreams and nightmares
Vivid or unusual dreams are reported by a significant number of people taking antidepressants, particularly with SSRIs and SNRIs. For some, this is mildly curious and not troublesome. For others, particularly those with a history of trauma or pre-existing nightmares, this can be highly distressing. It's worth mentioning this to your prescriber if you're experiencing it, as it's a recognised side effect and there are options to consider.
The timing of antidepressants and sleep
One practical point that is often overlooked is the timing of when antidepressants are taken. For activating medications, taking them late in the evening can worsen insomnia, and switching to a morning dose is sometimes all that's needed to make a real difference. For sedating medications, taking them too early in the evening can cause excessive drowsiness before bedtime. Evidence supports adjusting timing based on a medication's activating or sedating profile as a practical first step (ref).
This may sound simple, but in my experience it's a surprisingly underutilised adjustment. If you're having sleep problems on your antidepressant, it's absolutely worth discussing the timing with your prescriber before assuming a dose change or medication switch is needed.
Why these effects are often underreported and underdiscussed
As I'vewritten about before, there's a tendency in clinical practice to focus most attention on side effects in the early stages of treatment, particularly those that affect safety, like increased agitation or suicidal ideation. Sleep effects, like sexual dysfunction and emotional blunting, can receive less scrutiny over time, particularly once a patient seems to be doing reasonably well on their medication overall.
There's also a tendency for both patients and clinicians to normalise these effects. Patients may assume that sleep issues are "just the depression" rather than potentially caused by their medication, and without being asked directly, many won't volunteer these struggles. Clinicians, for their part, may not think to enquire about sleep quality specifically in the context of medication side effects, especially after the initial stages of treatment.
The result is that a significant number of people are quietly putting up with sleep disruption that is, at least in part, medication-related, and potentially missing out on adjustments that could make a real difference.
The longer-term picture: when sleep problems affect adherence
Poor sleep is exhausting and demoralising at the best of times. When it's being caused or worsened by a medication that is supposed to be helping you recover, it can understandably make people question whether to continue taking it at all. In my clinical experience, sleep-related side effects are one of the reasons people reduce their dose without telling their doctor, or quietly stop their medication altogether, both of which carry real risks in terms of withdrawal effects and relapse.
I can't stress this enough: please don't stop or reduce your antidepressant suddenly without first speaking to your prescriber. There is almost always something that can be done, whether that's a timing adjustment, a dose review, a switch to a different medication, or the addition of another treatment approach. But this needs to happen in a supported and planned way.
What can be done about antidepressant-related sleep problems?
There are several avenues worth exploring, ideally with your prescriber's guidance:
- Timing adjustment: Sometimes simply changing when you take your medication can make a meaningful difference to sleep and day-time functioning.
- Dose review: Side effects are often dose-dependent. If sleep problems emerged or worsened after a dose increase, it may be worth discussing whether the current dose is providing the right balance for you.
- Switching medication: Some antidepressants are less likely to disrupt sleep architecture than others. For those experiencing significant insomnia on an SSRI, for example, there may be alternatives worth considering.
- Sleep hygiene and CBT for insomnia (CBT-I): Behavioural approaches to sleep are well-evidenced and can be helpful alongside medication. CBT-I is recommended as the first-line treatment for insomnia by NICE (ref) and can complement antidepressant treatment well.
- Alternative treatment approaches for depression: For some people, having access to a treatment for depression that doesn't interfere with sleep quality and doesn't carry a sedation or insomnia burden is a high priority. The Flow headset, which uses transcranial direct current stimulation (tDCS) to treat depression, is one such option. It works by gently stimulating the left dorsolateral prefrontal cortex, the area of the brain we know to be underactive in depression, and has a minimal side effect profile. Unlike many antidepressants, Flow does not disrupt sleep architecture. A real-world analysis of over 6,000 Flow users found improvements in sleep quality were experienced by the majority, with a third achieving remission from insomnia after just one week of use (ref). Flow can be used as a standalone treatment or alongside medication, depending on individual circumstances.
The key message here is that sleep problems on antidepressants are not something you simply have to accept. There are options, and it's worth having that conversation with your clinician.
A note on stopping antidepressants and sleep
If you and your prescriber decide to reduce or stop your antidepressant, it's worth knowing that sleep disturbance, particularly vivid dreams or insomnia, can be a feature of antidepressant discontinuation, especially with SSRIs and SNRIs. This is one of the many reasons why coming off antidepressants should always be done gradually and with medical guidance. What can look like relapse of depression is sometimes, in part, a withdrawal effect, and understanding the difference matters.
My final takeaways
Sleep problems on antidepressants are common, underreported, and importantly, often addressable. If your sleep has changed since starting or adjusting your medication, please bring it up with your prescriber. It's a legitimate and important concern, and you shouldn't feel embarrassed or reluctant to raise it.
Depression is already exhausting. You deserve treatment that helps you feel better, and that includes sleeping well.
As always, please speak to your doctor or another qualified healthcare professional about your own situation. The information in this article is intended for general educational purposes and is not a substitute for personalised medical advice.
Dr Hannah Nearney MBChB, MRCPsych, MSc, PGDip(CAT) is a Consultant Psychiatrist specialising in general adult psychiatry, including adult ADHD, autism, and women's mental health. She is UK Medical Director at Flow Neuroscience and a founding partner at Anchor Psychiatry Group in East Anglia. She is a Fellow on the NHS Innovation Accelerator program (2026 cohort) which provides support to scale evidenced-based innovations like Flow tDCS in the NHS to enhance patient outcomes and service delivery. Follow her on Instagram: @psychiatristhannah
References:
1- Amerisleep, How Antidepressants Affect Sleep (2026)
Activating SSRIs/SNRIs and sleep disruption; REM suppression; effects typically stabilise after 2-4 weeks; dose timing guidance.
https://amerisleep.com/blog/how-antidepressants-affect-sleep/
2- GeneSight, Starting Antidepressants Timeline (2025)
Side effects most common in first 3 weeks or at dose changes. Quote from Shari Allen, PharmD. Symptom tracking guidance.
https://genesight.com/blog/starting-antidepressants-timeline-of-side-effects-and-adjustment/
3- The Better Sleep Clinic, Antidepressants and Sleep (2025)
Drug-by-drug insomnia vs sedation risk profiles. Zhou et al. 2023 meta-analysis. SSRI and SNRI sleep effects.
4- Blossom Health, Lexapro and Insomnia (2026)
9-14% experience insomnia on escitalopram. Sleep disruption typically emerges in weeks 1-2; improves within 4-6 weeks.
https://www.joinblossomhealth.com/blog/lexapro-and-insomnia
5- Flow Neuroscience, Evidence Page
Clinical trial finding: tDCS more effective when used alongside antidepressants than either treatment alone.